Locomotor activity and accumbens Fos expression driven by ventral hippocampal stimulation require D1 and D2 receptors

Neuroscience

Volumn 94, Issue 1, 1999, Pages 59-70

  Bardgett, M E ^a   Henry, J D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hippocampus; Immediate early gene; Locomotor activity; Nucleus accumbens; Rat; Schizophrenia

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMPA RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; HALOPERIDOL; RESERPINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE TIME EFFECT RELATION; HIPPOCAMPUS; IMMEDIATE EARLY GENE; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANESTHETICS, LOCAL; ANIMALS; BRAIN CHEMISTRY; CYCLOLEUCINE; DEXTROAMPHETAMINE; DOPAMINE AGENTS; DOPAMINE ANTAGONISTS; EXCITATORY AMINO ACID AGONISTS; GENES, IMMEDIATE-EARLY; GLUTAMIC ACID; HALOPERIDOL; HIPPOCAMPUS; KAINIC ACID; LIDOCAINE; LOCOMOTION; MALE; N-METHYLASPARTATE; NEURAL PATHWAYS; NEUROPROTECTIVE AGENTS; NUCLEUS ACCUMBENS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2;

EID: 0032860277     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00303-6     Document Type: Article

References (57)

1. Bardgett M.E., Jackson J.L., Taylor B.M., Csernansky J.G. The effects of kainic acid lesions on locomotor responses to haloperidol and clozapine. Psychopharmacology. 135:1998;270-278.
2. Bardgett M.E., Jacobs P.S., Jackson J.L., Csernansky J.G. Kainic acid lesions enhance locomotor responses to novelty, saline, amphetamine, and MK-801. Behav. Brain Res. 84:1997;47-55.
3. Baude A., Nusser Z., Roberts J.D.B., Mulvihill E., McIlhinney R.A.J., Somogyi P. The metabotropic glutamate receptor (mGluR1a) is concentrated at perisynaptic membrane of neuronal subpopulations as detected by immunogold reaction. Neuron. 11:1993;771-787.
4. Bischoff S. (1986) Mesohippocampal dopamine system: characterization, functional, and clinical implications. In The Hippocampus (eds Issacson R. L. and Pribram K. H.), Vol. 3, pp. 1-32. Plenum, New York.
5. Brenner D.M., Bardgett M.E. Haloperidol blocks increased locomotor activity elicited by carbachol infusion into the ventral hippocampal formation. Pharmac. Biochem. Behav. 60:1998;759-764.
6. Chen Z., Ito K., Fujii S., Miura M., Saski H., Kaneko K., Kato H., Miyakawa H. Roles of dopamine receptors in long-term depression: enhancement via D1 receptors and inhibition via D2 receptors. Receptor Channels. 4:1996;1-8.
7. Deutch A. Y. (1996) Sites and mechanisms of action of antipsychotic drugs as revealed by immediate-early gene expression. In Handbook of Experimental Pharmacology: Antipsychotics (ed. Csernansky J. G.), Vol. 120, pp. 117-164. Springer, Berlin.
8. Deutch A.Y., Cameron D.S. Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell. Neuroscience. 46:1992;49-56.
9. 14C]2-deoxyglucose autoradiographic study. J. Neurosci. 17:1997;4415-4425.
10. Fish D.R., Gloor P., Quesney F.L., Olivier A. Clinical responses to electrical brain stimulation of the temporal and frontal lobes in patients with epilepsy. Brain. 116:1993;397-414.
11. Flicker C., Geyer M.A. Behavior during hippocampal microinfusions. III. Lidocaine versus picrotoxin. Brain Res. Rev. 4:1982;129-136.
12. Flicker C., Geyer M.A. Behavior during hippocampal microinfusions. II. Muscarinic locomotor activation. Brain Res. Rev. 4:1982;105-127.
13. Floresco S.B., Seamans J.K., Phillips A.G. Differential effects of lidocaine infusions into the ventral CA1/subiculum or the nucleus accumbens on the acquisition and retention of spatial information. Behav. Brain Res. 81:1996;163-171.
14. Fotuhi M. Jr, Standaert D.G., Testa C.M., Penney J.B., Young A.B. Differential expression of metabotropic glutamate receptors in the hippocampus and entorhinal cortex of the rat. Molec. Brain Res. 21:1994;283-292.
15. Fu L., Beckstead R.M. Cortical stimulation induces fos expression in striatal neurons. Neuroscience. 46:1992;329-334.
16. Groenewegen H.J., Vermueulen-Van Der Zee E., Te Kortschot A., Witter M.P. Organization of the projection from the subiculum to the ventral striatum in the rat. A study using anterograde transport of Phaseolus vulgaris leucoagglutinin. Neuroscience. 23:1987;103-120.
17. Groenewegen H. J., Wright C. I. and Beijer A. V. J. (1996) The nucleus accumbens: gateway for limbic structures to reach the motor system? In Progress in Brain Research (eds Holstege G., Bandler R. and Saper C. B.), Vol. 107, pp. 485-511. Elsevier, Amsterdam.
18. Halgren E., Walter R.D., Cherlow D.G., Crandall P.H. Mental phenomena evoked by electrical stimulation of the human hippocampal formation and amygdala. Brain. 101:1978;83-117.
19. Heilig M., Engel J.A., Soderpalm B. C-fos antisense in the nucleus accumbens blocks the locomotor stimulant action of cocaine. Eur. J. Pharmac. 236:1993;339-340.
20. Johnson K., Churchill L., Klitenick M.A., Hooks M.S., Kalivas P.W. Involvement of the ventral tegmental area in locomotion elicited from the nucleus accumbens or ventral pallidum. J. Pharmac. exp. Ther. 277:1996;1122-1131.
21. Kalivas P.W., Duffy P., Barrow J. Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes. J. Pharmac. exp. Ther. 251:1989;378-387.
22. Kanai Y., Hediger M.A. Primary structure and functional characterization of a high-affinity glutamate transporter. Nature. 360:1992;467-471.
23. Klarner A., Koch M., Schnitzler H.-U. Induction of Fos-protein in the forebrain and disruption of sensorimotor gating following N-methyl-D-aspartate infusion into the ventral hippocampus of the rat. Neuroscience. 84:1998;443-452.
24. Kohler C., Ericson H., Radesater A.C. Different laminar distributions of dopamine D1 and D2 receptors in the rat hippocampal region. Neurosci. Lett. 126:1991;107-109.
25. Kusuki T., Imahori Y., Ueda S., Inokuchi K. Dopaminergic modulation of LTP induction in the dentate gyrus of intact rat. NeuroReport. 8:1997;2037-2040.
26. LaHoste G., Ruskin D., Marshall J. Cerebrocortical Fos expression following dopaminergic stimulation: D1/D2 synergism and its breakdown. Brain Res. 728:1996;97-104.
27. Lehre K.P., Levy L.M., Ottersen O.P., Storm-Mathisen J., Danbolt N.C. Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations. J. Neurosci. 15:1995;1835-1853.
28. Lipska B.K., Jaskiw G.E., Chrapusta S., Karoum F., Weinberger D.R. Ibotenic lesion of the ventral hippocampus differentially affects dopamine and its metabolites in the nucleus accumbens and prefrontal cortex in the rat. Brain Res. 585:1992;1-6.
29. Lipska B.K., Jaskiw G.E., Weinberger D.R. Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia. Neuropsychopharmacology. 9:1993;67-75.
30. Liste I., Rozas G., Guerra M.J., Labandeira-Garcia J.L. Cortical stimulation induces Fos expression in striatal neurons via NMDA glutamate and dopamine receptors. Brain Res. 700:1995;1-12.
31. Ma J.Y., Brudzynski S.M., Leung L.W.S. Involvement of the nucleus accumbens ventral pallidal pathway in postictal behavior induced by a hippocampal afterdischarge in rats. Brain Res. 739:1996;26-35.
32. MacLean P.D. The limbic system and its hippocampal formation, studies in animals and their possible application to man. J. Neurosurg. 11:1953;29-44.
33. Matthies H., Becker A., Schroeder H., Kraus J., Hollt V., Krug M. Dopamine D1-deficient mutant mice do not express the late phase of hippocampal long-term potentiation. NeuroReport. 8:1997;3533-3535.
34. Mogenson G.J., Nielsen M. A study of the contribution of hippocampal-accumbens-subpallidal projections to locomotor activity. Behav. neural Biol. 42:1984;38-51.
35. Morelli M., Cozzolino A., Pinna A., Fenu A., Di Chiara G. L-Dopa stimulates c-fos expression in dopamine denervated striatum by combined activation of D-1 and D-2 receptors. Brain Res. 623:1993;334-336.
36. Nakajima S., Franck J.E., Bilkey D., Schwartzkroin P.A. Local circuit synaptic interactions between CA1 pyramidal cells and interneurons in kainate-lesioned hyperexcitable hippocampus. Hippocampus. 1:1991;67-78.
37. Ogren S. O. (1996) The behavioral pharmacology of typical and atypical antipsychotic drugs. In Handbook of Experimental Pharmacology: Antipsychotics (ed. Csernansky J. G.), Vol. 120, pp. 117-164. Springer, Berlin.
38. Otmakhova N.A., Lisman J.E. D1/D5 dopamine receptors inhibit depotentiation at CA1 synapses via cAMP-dependent mechanism. J. Neurosci. 18:1998;1270-1279.
39. Packard M.G., McGaugh J.L. Inactivation of hippocampus or caudate nucleus with lidocaine differentially affects expression of place and response learning. Neurobiol. Learn. Mem. 65:1996;65-72.
40. Parthasarathy H.B., Graybiel A.M. Cortically driven immediate early gene expression reflects modular influence of sensorimotor cortex on identified striatal neurons in the squirrel monkey. J. Neurosci. 17:1997;2477-2491.
41. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates, 2nd edn. Academic, Sydney.
42. Petralia R.S., Yokotani N., Wenthold R.J. Light and electron microscope distribution of the NMDA receptor subunit NMDAR1 in the rat nervous system using a selective anti-peptide antibody. J. Neurosci. 14:1994;667-696.
43. Roe D.L., Bardgett M.E., Csernansky C.A., Csernansky J.G. Induction of fos protein by antipsychotic drugs in rat brain following kainic acid-induced limbic-cortical neuronal loss. Psychopharmacology. 138:1998;151-158.
44. Rogers S.W., Hughes T.E., Hollmann M., Gasic G.P., Deneris E.S., Heinemann S. The characterization and localization of the glutamate receptor subunit GluR1 in the rat brain. J. Neurosci. 11:1991;2713-2724.
45. Sacaan A.I., Schoepp D.D. Activation of hippocampal metabotropic excitatory amino acid receptors leads to seizures and neuronal damage. Neurosci. Lett. 139:1992;77-82.
46. Sesack S.R., Pickel V.M. In the rat nucleus accumbens, hippocampal and catecholaminergic terminals converge on spiny neurons and are in apposition to each other. Brain Res. 527:1990;266-279.
47. Sheng M., Greenberg M.E. The regulation and function of c-fos and other immediate early genes in the nervous system. Neuron. 4:1990;477-485.
48. Shigemoto R., Nakanishi S., Mizuno N. Distribution of the mRNA for a metabotropic glutamate receptor (mGluR1) in the central nervous system: an in situ hybridization study in adult and developing rat. J. comp. Neurol. 322:1992;121-135.
49. Shigemoto R., Nomura S., Ohishi H., Sugihara H., Nakanishi S., Mizuno N. Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain. Neurosci. Lett. 163:1993;53-57.
50. Stevens J.R., Mark V.H., Erwin F., Pacheco P., Suematsu K. Deep temporal stimulation in man, long latency, long lasting psychological changes. Archs Neurol. 21:1969;157-169.
51. Tarazi F.I., Kula N.S., Baldessarini R.J. Regional distribution of dopamine D4 receptors in rat forebrain. NeuroReport. 8:1997;3423-3426.
52. Tizzano J.P., Griffey K.I., Schoepp D.D. Induction or protection of limbic seizures in mice by mGluR subtype selective agonists. Neuropharmacology. 34:1995;1063-1067.
53. Waters N., Svensson K., Haadsma-Svensson S.R., Smith M.W., Carlsson A. The dopamine D3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity. J. neural Transm. 94:1993;11-19.
54. Wirtshafter D., Asin K. Interactive effects of stimulation of D1 and D2 dopamine receptors on Fos-like immunoreactivity in the normosensitive rat striatum. Brain Res. Bull. 35:1994;85-91.
55. Wu M., Brudzynski S.M. Mesolimbic dopamine terminals and locomotor activity induced from the subiculum. NeuroReport. 6:1995;1601-1604.
56. Yamada K.A., Tang C.-M. Benzothiadiazides inhibit rapid glutamate receptor desensitization and enhance glutamatergic synaptic currents. J. Neurosci. 13:1993;3904-3915.
57. 2 receptors in the nucleus accumbens: an electrophysiological and behavioural study. Neuroscience. 23:1987;1041-1055.